The tentative approval for ANDA 218862 was posted to the Drugs@FDA site.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AMRX:
- Amneal Pharmaceuticals backs prior FY24 EPS view 57c-63c, consensus 61c
- Amneal Pharmaceuticals Maintains Transparency with SEC Filing
- Amneal Pharmaceuticals director Patel sells 62,590 class A shares
- Appeals court sides with Amneal over Teva in inhaler patent fight
- Amneal resubmits DHE autoinjector NDA, gets FDA approval for exenatide
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue